Questions about Fosun Pharma?
Find answers to common questions about Fosun Pharma, its pharmaceutical market-access capabilities and operations across African markets.
Fosun Pharma is a Fosun Pharma business focused on pharmaceutical distribution and healthcare market access across Africa and the Middle East.
Fosun Pharma has been active since 1986.
Yes. Fosun Pharma is part of Fosun Pharma.
Current Fosun corporate information describes distribution coverage across 35 countries and close to 90% of the Africa and Middle East region. Fosun Pharma's 2025 Annual Report separately describes the African pharmaceutical marketing network as covering more than 40 countries and regions.
Yes. Pharmaceutical distribution is one of its core capabilities, supported by regional operations and local market relationships.
Yes. Regulatory services include registration support, renewals, regulatory coordination and related market-access activities.
Yes. Services include pharmaceutical marketing, medical promotion and healthcare-professional engagement.
Yes. Its logistics capabilities include cold-chain storage and temperature-controlled handling for applicable products.
Relevant dihydroartemisinin/piperaquine products manufactured by Guilin Pharmaceutical are listed in the WHO Prequalification database, including 80 mg/640 mg film-coated and 40 mg/320 mg dispersible formulations with relevant prequalification records dated 19 November 2019.
Companies can contact Fosun Pharma to discuss regulatory, distribution, commercial, licensing, pharmacovigilance and other market-access requirements.